6505--Sevelamer Carbonate Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) National Acquisition Center intends to issue an unrestricted Request for Proposal (RFP) #36E79726R0023 for Sevelamer Carbonate Tablets. This procurement aims to secure an uninterrupted source of supply for the VA (including Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (including Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The solicitation is expected on or about May 5, 2026, with proposals tentatively due by May 19, 2026.
Scope of Work
The successful offeror will provide Sevelamer Carbonate 800MG Tablets in 270-count bottles. The estimated annual usage is 42,891 bottles. Key product specifications include:
- Packaging: Unit of use bottles must have a safety-cap (deshellable or convertible to non-safety), a minimum 120cc volume, cylindrical body, and a minimum 5.75" circumference. The bottle must accommodate a 5.25" x 2" label with an additional 0.5" space for barcodes/expiration dates.
- Labeling: Products must feature the exact drug name on the label and a unique NDC number specific to the offeror. The successful offeror's label shall be the only one on the product, with VA labels designed to adhere securely on top.
Contract Details
- Contract Type: One contract will be awarded, structured as a commercial item procurement in accordance with FAR Part 12.
- Period of Performance: One base year plus four pre-priced one-year option periods.
- Distribution: Contracted items will be distributed through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
- Set-Aside: Unrestricted.
- NAICS Code: 325412 (Drugs And Biologicals).
Submission & Timeline
- Solicitation Release: On or about May 5, 2026.
- Proposal Due Date: Tentatively May 19, 2026, 2:30 PM Central Time.
- Submission Method: Electronically via SAM.gov. No paper copies will be available.
- Point of Contact: Matthew Poulin, Contract Specialist, matthew.poulin@va.gov.
Important Notes
Interested offerors are advised to continuously monitor SAM.gov for the official solicitation, any amendments, and other miscellaneous documents. All responsible sources are encouraged to submit a timely offer.